Investigating a universal vaccine for influenza
NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities
This study is looking at how flu viruses change and spread, and how our immune system responds to them, to help create better vaccines that can protect us from different types of the flu.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Georgia NIH-funded |
| Lab location | 1 site (Athens, United States) |
| Project ID | NIH-11301789 on NIH RePORTER |
What this research studies
This research focuses on understanding the factors that influence the evolution and transmission of influenza viruses, as well as the immune response to these infections. By conducting cohort studies and sampling from both humans and animals, the research aims to identify key immunological factors that could lead to better protection against influenza. The goal is to improve vaccination strategies and develop a universal influenza vaccine that offers broader protection against various strains of the virus.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals who are at risk of influenza infection, such as those with compromised immune systems or chronic health conditions.
Not a fit: Patients who are not at risk for influenza or those who have already received effective vaccination may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of a universal influenza vaccine, significantly reducing the incidence of flu infections and improving public health.
How similar studies have performed: Previous research has shown promise in developing universal vaccines for influenza, indicating that this approach has potential for success.
Where this research is happening
Athens, United States
- University of Georgia — Athens, United States (Active)
Researchers
- Principal investigator: Tompkins, S. Mark — University of Georgia
- Study coordinator: Tompkins, S. Mark
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.